drugset / Trial / NCT01192581

Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection as Adjunctive Therapy in Subjects With Internal Carotid Artery Hypoperfusion

NCT01192581 ↗

Phase 2 Unknown 120 enrolled Xijing Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to evaluate the effectiveness, safety and tolerability of consistent dosages of the study drug (hydroxyethyl starch 130/0.4 and sodium chloride injection, Vuloven) administrated intravenously for 7 days.

Timeline

Start
2010-08
Primary completion
2011-04
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Vuloven Unknown 500 mg Intravenous
Subject Vuloven Unknown 1000 mg Intravenous
Subject Vuloven Unknown 1500 mg Intravenous